Article

Received 20.10.2025

Revised 23.01.2026

Accepted 25.02.2026

Retrieved from Vol. 2, No. 1, 2026

Pages 18 -27

Maamatova, B., Orunbaeva, B., Bolokbaeva, R., Edilbekova, A., & Omorbekova, E. (2026). Current trends and epidemiological features of genitourinary diseases in the Osh region. Journal of Human Biology and Clinical Medicine, 2(1), 18-27. https://doi.org/10.63621/jhbcm/1.2026.18

Current trends and epidemiological features of genitourinary diseases in the Osh region

Burulkan Maamatova, Bibigul Orunbaeva, Rahat Bolokbaeva, Almagul Edilbekova, Elizat Omorbekova

Diseases of the genitourinary system represent a significant medical and social problem, substantially affecting quality of life, ability to work, and demographic indicators. The aim of this study was to examine overall morbidity and primary incidence of genitourinary diseases among the adult and paediatric population of the Osh region over the study period. The research was based on an analysis of official statistical data from regional medical institutions and the Ministry of Health. The findings indicated that overall morbidity and primary incidence showed a downward trend following a period of increase, which was associated with restrictions on preventive examinations and a rise in chronic infections. Significant gender differences were identified: women were more likely to suffer from inflammatory conditions, whereas men more frequently experienced prostate disorders and urolithiasis. It was concluded that systematic monitoring and analysis of urological morbidity are essential for improving preventive measures, increasing access to healthcare, and developing regional public health programmes. After reaching a peak in 2021 (45,870 per 100,000 population), overall morbidity decreased to 33,240 cases by 2024, while primary incidence declined from 22,480 to 17,210 per 100,000 population. Kidney and urinary tract diseases predominated (67.5%), with chronic pyelonephritis accounting for 26.9%. The incidence rate among women was, on average, 2.1 times higher than among men. The obtained results can be used to plan regional prevention programmes, optimise patient routing, and improve the effectiveness of urological care in medical institutions in the Osh region

urological pathologies, urinary tract infections, nephrological disorders, prevalence structure, population analysis, dynamics of urological diseases, sanitary and demographic characteristics
  1. World Health Organization. World Health Statistics 2025 [Internet]. [cited 2025 June 27]. Available from: https://www.who.int/publications/b/78420
  2. National Statistical Committee of the Kyrgyz Republic. Health statistics [Internet]. [cited 2025 April 12]. Available from: https://stat.gov.kg/ru/statistics/zdravoohranenie/
  3. Broughton E, Bektas M, Colosia A, Kuper K, Fernandez MM, Al-Taie A, et al. A systematic literature review of the epidemiology of complicated urinary tract infection. Infect Dis Ther. 2025;14(6):1157–81. DOI: 10.1007/s40121-025-01149-8
  4. He Y, Zhao J, Wang L, Han C, Yan R, Zhu P, et al. Epidemiological trends and predictions of urinary tract infections in the global burden of disease study 2021. Sci Rep. 2025;15(1):4702. DOI: 10.1038/s41598-025-89240-5
  5. Al Lawati H, Blair BM, Larnard J. Urinary tract infections: Core Curriculum 2024. Am J Kidney Dis. 2024;83(1):90–100. DOI: 10.1053/j.ajkd.2023.08.009
  6. Gottlieb M, Amponsah T, Bernard K, Moyer E. Epidemiology of urinary tract infections in adults among United States emergency departments from 2016 to 2023. Am J Emerg Med. 2025;93:7–12. DOI: 10.1016/j.ajem.2025.03.038
  7. Yoon C, Kim J, Jang W, Ko JW, Kim J, Pai H, et al. Clinical and microbiological characteristics of female patients with acute pyelonephritis who experienced urinary tract infections within the previous year. J Infect Public Health. 2024;17(2):349–58. DOI: 10.1016/j.jiph.2023.12.011
  8. Hsu YH, Hou CP, Weng SC, Tsai HY, Tsao SH, Juang HH, et al. Analysis of urinary retention after endoscopic prostate enucleation and its subsequent impact on surgical outcomes. World J Urol. 2024;42(1):305. DOI: 10.1007/s00345-024-04918-1
  9. Ministry of Health of the Kyrgyz Republic. Statistical reporting forms on morbidity [Internet]. [cited 2025 September 14]. Available from: https://med.kg/
  10. World Health Organization. International statistical classification of diseases and related health problems [Internet]. 2019 [cited 2025 August 15]. Available from: https://icd.who.int/browse10/2019/en?referrer
  11. Lai S, Luciani LG, Cai T, Corgna S, Pastore A, Celi G, et al. Chronic kidney disease and urological disorders: systematic use of uroflowmetry in nephropathic patients. Clin Kidney J. 2019;12(3):414–9. DOI: 10.1093/ckj/sfy116
  12. Ciccarese F, Brandi N, Corcioni B, Golfieri R, Gaudiano C. Complicated pyelonephritis associated with chronic renal stone disease. Radiol Med. 2021;126(4):505–16. DOI: 10.1007/s11547-020-01315-7
  13. Cormio L, Calò B, Falagario U, Iezzi M, Lamolinara A, Vitaglione P, et al. Improvement of urinary tract symptoms and quality of life in benign prostate hyperplasia patients associated with consumption of a newly developed whole tomato-based food supplement: a phase II prospective, randomized double-blinded, placebo-controlled study. J Transl Med. 2021;19(1):24. DOI: 10.1186/s12967-020-02684-3
  14. Aibashov MN, Baiyzbekova DA, Kasymova RO, Kenenbaeva RM. Epidemiological analysis of indicators of prevalence and morbidity of diseases of the genitourinary system of the population of reproductive age in the Kyrgyz Republic. Int J Appl Fundam Res. 2018;12(2):225–9.
  15. Ademola BL, Atanda AT, Aji SA, Abdu A. Clinical, morphologic and histological features of chronic pyelonephritis: An 8-year review. Niger Postgrad Med J. 2020;27(1):37–41. DOI: 10.4103/npmj.npmj_109_19
  16. Flores-Mireles AL, Walker JN, Caparon M, Hultgren SJ. Urinary tract infections: Epidemiology, mechanisms of infection and treatment options. Nat Rev Microbiol. 2015;13(5):269–84. DOI: 10.1038/nrmicro3432
  17. Herness J, Buttolph A, Hammer NC. Acute pyelonephritis in adults: Rapid evidence review. Am Fam Physician. 2020;102(4):173–8.
  18. Choi EJ, Xu P, Barham D, El-Khatib FM, Amini A, Djaladat H, et al. Comparison of outcomes for hypogonadal men treated with intramuscular testosterone cypionate versus subcutaneous testosterone enanthate. J Urol. 2022;207(3):677–83. DOI: 10.1097/JU.0000000000002301
  19. Kurmanbekova T, Toguzbaeva K, Dzhusupov K, Tazhiyeva A. The dynamics of morbidity and provision of urological resources in the Republic of Kazakhstan. Clin Epidemiol Glob Health. 2024;25:101700. DOI: 10.1016/j.cegh.2024.101700
  20. Zhakhina G, Mussina K, Yerdessov S, Gusmanov A, Sakko Y, Kim V, et al. Analysis of chronic kidney disease epidemiology in Kazakhstan using nationwide data for 2014-2020 and forecasting future trends of prevalence and mortality for 2030. Ren Fail. 2024;46(1):2326312. DOI: 10.1080/0886022X.2024.2326312
  21. GBD Chronic Kidney Disease Collaboration. Global, regional, and national burden of chronic kidney disease, 1990-2017: A systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2020;395(10225):709–33. DOI: 10.1016/S0140-6736(20)30045-3
  22. Medina M, Castillo-Pino E. An introduction to the epidemiology and burden of urinary tract infections. Ther Adv Urol. 2019;11:1756287219832172. DOI: 10.1177/1756287219832172